Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
01/27/2005 | WO2004066959A3 Organic-arsonic compounds |
01/27/2005 | US20050020857 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
01/27/2005 | US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
01/27/2005 | US20050020835 Preparation of phosphorus compounds |
01/27/2005 | US20050020834 Method for preparation of sulphostin and its analogue or intermediates thereof |
01/27/2005 | US20050020801 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins |
01/27/2005 | US20050020800 Oligomeric, hydroxy-terminated phosphonates |
01/27/2005 | US20050020739 Derivatives of 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide |
01/27/2005 | US20050020595 Compounds, methods and pharmaceutical compositions for inhibiting PARP |
01/27/2005 | US20050020559 Vision defects; cardiovascular disorders; skin disorders; anticancer agents |
01/27/2005 | US20050020544 Using pinene compound; prevention, therapy of autoimmune disease; antiarthritic agents; multiple sclerosis; lupus; antidiabetic agents; psoriasis; antihistamines; cardiovascular disorders; analgesics |
01/27/2005 | US20050020543 Hexa-citrated phytate and process of preparation thereof |
01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
01/27/2005 | US20050019978 Systems and methods for forming tantalum oxide layers and tantalum precursor compounds |
01/27/2005 | US20050017222 Flame-retardant compositions of methanephosphonic acid, boric acid and an organic base |
01/27/2005 | DE10331496A1 Verfahren zum Herstellen von Difluoracetessigsäurealkylestern A process for producing Difluoracetessigsäurealkylestern |
01/27/2005 | DE102004033306A1 Preparation of silyl esters of phosphoric and phosphinic acids is effected in a multi-phase system with activated silanes and a formamide solvent aid, the products also being de-protected by splitting off silyl groups |
01/27/2005 | CA2531596A1 Fluorocombretastatin and derivatives thereof |
01/27/2005 | CA2531389A1 Combretastatin derivatives with cytotoxic action |
01/26/2005 | EP1500969A1 Compound and its use in electrochromic devices |
01/26/2005 | EP1499898A2 Regulation of tnf-alpha |
01/26/2005 | EP1499609A2 Pesticidal heterocycles |
01/26/2005 | EP1499587A1 Process for synthesizing pharmaceutically active disulfide salts |
01/26/2005 | EP1499577A1 2-(2,6-dichlorophenyl)-diarylimidazoles |
01/26/2005 | EP1370564B1 Resveratrol-phospholipids complexes |
01/26/2005 | EP1311514B1 Compositions with vascular damaging activity |
01/26/2005 | EP1296993B1 Metallic compounds and the use thereof in the polymerisation of olefins |
01/26/2005 | EP1177310B1 Method for producing l-phosphinothricine by enzymatic transamination with aspartate |
01/26/2005 | CN1569861A Pharmaceutical acid addition salt of adefovir dipivoxil and its pharmaceutical use |
01/26/2005 | CN1569860A Diol containing phosphatidylcholine and use thereof |
01/26/2005 | CN1569829A Method for preparing 2-amino-4-methylthio-(s-oxo-s-imino)-butyric acid phosphate or succinate |
01/26/2005 | CN1186342C Substituted (4-bromopyrazole-3-yl) indole |
01/26/2005 | CN1186125C Chirality catalyst for oxygenized dinaphthol |
01/25/2005 | US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
01/25/2005 | US6846925 Colchinol derivatives as angiogenesis inhibitors |
01/25/2005 | US6846922 Activators for oligonucleotide synthesis |
01/25/2005 | US6846771 Metal complexes of iminohydroxamic acids |
01/25/2005 | US6846769 For ethylene/propylene or ethylene/ alpha-olefin copolymerization and terpolymerization of those monomers with dienes |
01/25/2005 | US6846419 Phosphonamide and phosphonamide blend compositions and method to treat water |
01/25/2005 | CA2123079C Enzymatic preparation of n-(phosphonomethyl) glycine |
01/25/2005 | CA2097384C Dithiophosphoric acid derivatives as lubricant additives |
01/20/2005 | WO2005006807A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
01/20/2005 | WO2005006806A1 Wireless microphone communication system |
01/20/2005 | WO2005005519A1 Method for producing phosphonate-modified silicones |
01/20/2005 | WO2005005447A2 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
01/20/2005 | WO2005005440A2 Novel organosilicon compounds and a method for their production |
01/20/2005 | WO2005005399A1 Oxazolidinone antibiotics and derivatives thereof |
01/20/2005 | WO2005004897A1 Water-soluble shps as novel alkylating agents |
01/20/2005 | WO2004098772A3 Phospholane salts and their use in enantioselective hydrogenation |
01/20/2005 | WO2004085448A3 Unsaturated phosphinyl-phosphonate phosphate transport inhibitors |
01/20/2005 | WO2004058787A3 Fluorogenic enzyme substrates and methods of preparation |
01/20/2005 | US20050014971 Enanitomers of unsaturated alkyllysophosphonocholines and use as anti-neoplastics |
01/20/2005 | US20050014962 Novel lipids for transfection of nucleic acids |
01/20/2005 | US20050014954 Pyrrole synthesis |
01/20/2005 | US20050014946 Substituted amino ketone compounds |
01/20/2005 | US20050014802 Prevent reproduction of virus; antitumor agents |
01/20/2005 | US20050014728 Therapy or prevention of diseases caused by lymphocyte interaction; antiinflamamtory agents; autoimmune disease |
01/20/2005 | US20050014727 Antiinflammatoy agents; antiallergens; antiproliferative agents; skin disorders; viral disorders; Alzheimer's disease; muscular disorders; antiarthritic agents |
01/20/2005 | US20050014725 Immunosuppressant compounds and compositions |
01/20/2005 | US20050014724 Immunosuppressant compounds and compositions |
01/20/2005 | US20050014723 Administering a lysophosphatidylic acid compound |
01/20/2005 | US20050014722 Process for preparing n-acylated lysophosphatidylcholine and pharmaceutical composition for treatment of metabolic bone disease comprising said compounds |
01/20/2005 | US20050014633 Biphenyldiphosphine compounds |
01/20/2005 | US20050014024 Coordination compounds; luminescence efficiency; stability |
01/20/2005 | US20050011405 Red fluorescent material and composition containing the same |
01/20/2005 | CA2530193A1 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
01/20/2005 | CA2529292A1 Oxazolidinone antibiotics and derivatives thereof |
01/20/2005 | CA2525091A1 Water-soluble shps as novel alkylating agents |
01/19/2005 | EP1498420A1 Phospholipid derivative |
01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
01/19/2005 | EP1498405A1 Liquid vegetable unsaturated alcohol and process for producing the same |
01/19/2005 | EP1497300A2 Plasma carboxypeptidase b inhibitors |
01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
01/19/2005 | EP1497248A1 Method for producing ethers, esters or acid anhydrides |
01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
01/19/2005 | EP1497245A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
01/19/2005 | EP1496889A1 Stabilized ascorbic acid derivatives |
01/19/2005 | EP1294657B1 Catalysis using phosphine oxide and sulfoxide compounds |
01/19/2005 | EP1181271B1 Naphthalene ureas as glucose uptake enhancers |
01/19/2005 | EP1089988A4 Fluorophenyl resin compounds |
01/19/2005 | EP0833899B1 Cis-9,10-octadecenoamidase |
01/19/2005 | CN1568344A Higher alkylated triaryl phosphate ester flame retardants |
01/19/2005 | CN1568304A Process for the preparation of enantiomerically-enriched cyclopropylalanine derivatives |
01/19/2005 | CN1568226A Phosphonites |
01/19/2005 | CN1568225A Phosphinites |
01/19/2005 | CN1566123A Solvent-free method for preparing sterically hindered phosphoramidates |
01/19/2005 | CN1566122A 3-methyl-2-amylene-4-alkyne-1-triphenyl phosphine halide and preparation method thereof |
01/19/2005 | CN1566121A 3-methyl-2-amylene-4-alkyne-1-phosphonate ester compound and preparation method thereof |
01/19/2005 | CN1566120A Synthetic method of linear low molecular alkoxy phosphonitrile compound |
01/19/2005 | CN1185259C Fluorophenyl resin compounds |
01/19/2005 | CN1185240C Process for one-stage synthesizing substituted diaryl organic metal phosphate |
01/19/2005 | CN1185216C Fungicides |
01/18/2005 | US6844462 Biphenydiols |
01/18/2005 | US6844461 Synthesis of A-ring synthon of 19-NOR-1α,25-dihydroxyvitamin D3 from (D)-glucose |
01/18/2005 | US6844458 Vegetable oil refining |
01/18/2005 | US6844437 Chemical intermediates; anticholesterol agents, antilipemic agents |
01/18/2005 | US6844433 Nucleic acid labeling compounds |
01/18/2005 | US6844404 Catalyst compositions for the polymerization of olefins |
01/18/2005 | US6844289 Process for the preparation of a nickel/phosphorous ligand catalyst |
01/18/2005 | US6843979 Radiolabeled compounds useful as imaging agents for visualizing the location and density of serotonin transporter by tomography imaging; as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction |